Oxycodone Hydrochloride Tablets, USP (CII), 5 mg
Recalled by Amerisource Health Services LLC
Class II — moderate
Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Amerisource Health Services LLC has recalled Oxycodone Hydrochloride Tablets, USP (CII), 5 mg, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on February 18, 2026 and was initiated on January 14, 2026. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers Oxycodone Hydrochloride Tablets, USP (CII), 5 mg, with approximately 31,676 packages affected. The company behind the recall is Amerisource Health Services LLC, based in Columbus, OH. The FDA describes the product as: “Oxycodone Hydrochloride Tablets, USP (CII), 5 mg, 100-Count (10 x 10) blister cards per carton, Rx Only, The drug product contained in this package is from NDC # 10702-018, KVK-Tech Inc. Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton…”
Why was Oxycodone Hydrochloride Tablets, USP (CII), 5 mg recalled?
According to the FDA, the stated reason for the recall is: “Defective container: card seal defects (weak/non-existent seals), leading to the tablets falling out of their cavities.”
What should you do?
If you think you may have bought Oxycodone Hydrochloride Tablets, USP (CII), 5 mg, compare it against the product description and identifying codes (Lots #: 1027932, Exp Date 06/30/2027, 1028360, Exp Date 08/31/2027) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Amerisource Health Services LLC or your local health authority.
About this recall
This recall was distributed in OH. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- February 18, 2026
- Recall started
- January 14, 2026
- Distributed in
- OH
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was Oxycodone Hydrochloride Tablets, USP (CII), 5 mg recalled?+
According to the FDA: Defective container: card seal defects (weak/non-existent seals), leading to the tablets falling…
How serious is this recall?+
Class II — moderate. Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
What should I do if I have Oxycodone Hydrochloride Tablets, USP (CII), 5 mg?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0338-2026. Information last synced from the FDA on July 6, 2026.